Global health diagnostics provider Randox has maintained its status as a significant competitor in the Asian market by participating in the NCML Exhibition in Hangzhou. The NCLM is the largest laboratory equipment exhibition in China dedicated to the advancement of diagnostic equipment and is an annual staple of the country’s top medical equipment firms. Also attracting some of China’s top clinical science talents, the exhibit was held in the capital of China’s Zhejiang province on 20th September.
In-vitro diagnostic (IVD) equipment, which enables diagnosis and monitoring of samples taken from the body, was the sole focus of the exhibition but an essential aspect of the IVD process is Quality Control. The Quality Control Market is a lucrative one and continues to grow – estimated to be worth $1.04 billion by 2022.
Over many years, Randox has developed the largest global EQA (External Quality Assurance) scheme available on the market, RIQAS, which offers laboratories around the world assurance that the results they are releasing are accurate and reliable. With just under 40, 000 participants in 132 countries and 32 flexible programmes, it is little wonder that the global health technology giant is predicting huge growth in Chinese territories.
Randox has been involved in trade in China for over 20 years and has been making significant strides in the Asian market recently through a strategic Chinese market expansion launch in December 2016. This expansion has included the securing of distributors across four of the largest provinces in China and partnerships with hospitals in Guangzhou, Shanghai and Wuhan.
Preceding the NCML Exhibition, in February 2017, Randox launched a major recruitment drive to hire Mandarin-speaking graduates in Northern Ireland who could join the sales, marketing and scientific teams in China. The company, which employs over 1,400 workers worldwide, was supported by Ulster University and its Confucius Institution in this recruitment campaign.
Ying Zhu, Sales Manager for Randox Laboratories in China, commented on the success Randox has seen in China over the last ten months;
“China is one of our key markets and we were delighted to showcase our capabilities at China’s largest IVD equipment exhibition recently. Randox in China has been growing from strength to strength in the last year, building on a solid foundation laid in 20 years of trade with the country. We continue to increase our presence in the Asian market thanks to increased output from our innovative R&D programmes, and enhanced manufacturing capabilities, including new facilities at the Randox Science Park, our new headquarters in Antrim. These infrastructural developments have resulted in an increasing range of products which we can now offer to growing and dynamic markets such as China. This increasing range of products coupled with a growing market presence has significantly increased our business penetration and subsequent support to customers.”
Margaret Fick, RIQAS Scientist added;
“At our most recent training conference in China, we were very pleased to host several of our newly acquired hospital partners who presented to our audience how many laboratories have benefitted from our Randox Quality Control products. The testimonials from high profile individuals who have experienced the quality, efficiency and reliability of our products is accelerating our growth across China. Our inclusion at the NCLM Exhibition marks another cornerstone in Randox’s expansion in China.”
For further information about NCLM, please contact Randox PR by phoning 028 9445 1016 or emailing RandoxPR@randox.com
Ulster University’s GAA team is preparing to travel to China on an historic tour of the country as part of the university’s wider programme of engagement in key international markets.
The trip, which will be sponsored by Crumlin-based diagnostics firm Randox, will see a 35 strong team depart on 28 October for a two week cultural exchange that aims to develop and enhance links with a number of Chinese academic institutions.
The team will travel to Beijing, Wuhan, and Huangshi City and play several games as part of an extensive tour promoting sporting excellence at Ulster University and Gaelic Games in particular.
Professor Ian Montgomery, Pro-Vice Chancellor, Global Engagement at Ulster University said:
“GAA is of increasing interest to the Chinese people and there is a strong appetite to learn about the various sports, key tactics and the strong cultural identity which Ulster University’s GAA team has developed over many decades. This tour, supported by Randox, will give our team the opportunity to showcase Gaelic football and hurling to a vast audience which is interested to learn more and experience a game first-hand through a number of Gaelic Games masterclasses.”
“As an internationally focused university it is important to continually build new partnerships in this vast market and further enhance existing linkages. From research collaborations with some of China’s top universities to our role as home to the Confucius Institute and Confucius classrooms initiative in Northern Ireland, China remains a significant market with clear potential for growth. We look forward to building on our work in this region and meeting new connections as part of the tour.”
Dr Peter FitzGerald, founder of Randox, said:
“We are pleased to support Ulster University’s Gaelic team as they embark on a very exciting tour of China. It is one of our most important markets, as we have been exporting to China since 1992 and we have had an established presence in the region for several years. This is a brilliant opportunity for our partnership with Ulster University to profile some of the young sporting talents of Northern Ireland and to strengthen key business relationships in an important market.”
For further information about the Randox-sponsored GAA tour, please contact Randox PR by phoning 028 9445 1016 or emailing RandoxPR@randox.com
Following the launch of its new Chinese market expansion programme in December 2016, global healthcare diagnostics company Randox Laboratories has made significant strides in its business with China, successfully increasing its exports and enabling new business opportunities within the country.
The firm has just returned from a business trip to China to meet new distributors and customers acquired over the last six months, and to train this recently acquired distributor network on Randox’s latest healthcare technologies, with a key focus on the company’s RIQAS programme, the world’s largest External Quality Assessment scheme for laboratories.
Ying Zhu, Sales Manager for Randox Laboratories in China, commented on the success Randox has seen in China over the last six months;
“China is one of our key markets and although our world-leading diagnostic products have been sold there for more than 20 years, we continue to increase our business presence there thanks to increased output from our innovative R&D programmes, and enhanced manufacturing capabilities, including new facilities at the Randox Science Park, our new headquarters in County Antrim. These infrastructural developments have resulted in an increasing range of products which we can now offer to growing and dynamic markets such as China. This increasing range of products coupled with a growing market presence has significantly increased our business penetration and subsequent support to customers.”
Since the launch of the market expansion programme last year Randox has successfully secured distributors across four of the largest provinces of China and has partnered with key hospitals in Guangzhou, Shanghai and Wuhan.
Margaret Fick, RIQAS Scientist added;
“At our most recent training conference in China, in addition to the educational seminars I conducted with my colleagues, we were also delighted to be able to host several of our newly acquired hospital partners, who presented to our audience of current and potential customers on how their laboratories have benefited from our Randox Quality Control products. The use of testimonials from high profile individuals who have experienced the quality, efficiency and reliability of our products is accelerating our growth across China and this is set to continue over the coming months and years.”
For further information about Randox in China please contact Randox PR on 028 9445 1016 or email RandoxPR@randox.com
Following 18 months of extensive market research and infrastructural developments, global healthcare diagnostics company Randox Laboratories has this week launched a new market expansion programme in Shanghai in China, to help develop and strengthen business relationships and increase exports.
To mark the roll out of the initiative, Randox is hosting a conference in Shanghai for its most recently acquired distributor networks, who will benefit from training on Randox’s latest healthcare technologies, designed to facilitate early and accurate diagnosis to improve patient outcomes.
Susan Hammond, Global Product Manager at Randox Laboratories, commented on Randox’s Chinese expansion plans at the company’s Shanghai training conference;
“China is one of our most important markets and we have been exporting our world-class diagnostic products there for over 20 years. With increased output from our innovative R&D programmes, and enhanced manufacturing capabilities, including new facilities at Randox Science Park, we have an increasing range of high quality products, which are in demand in growing and dynamic markets such as China. We are now actively growing our market presence in order to improve our penetration and subsequent support to customers.”
As well as providing education on the latest diagnostic developments to conference attendees, Randox are also hosting over 300 guests at Camerata Ireland Concerts in Shanghai, Beijing and Wuhan over the coming week. Randox are Global Sponsors of Camerata Ireland and are delighted to showcase to Chinese audiences not only the science and innovation that come from our shores, but also the breadth of cultural talent.
“Our infrastructural changes within the Chinese market have been in planning and development for the last 18 months and we are delighted that our support of the talented Camerata Ireland orchestra on their Chinese tour this month gives us the opportunity to visit key business partners while simultaneously supporting our young musicians in their careers.”
The Camerata Ireland Orchestra, whose joint patrons are Michael D Higgins, President of Ireland and Queen Elizabeth II, begin their tour on the 9th December in Shanghai, when the all-Ireland orchestra will perform a diverse tapestry of classical music, led by Camerata Ireland founder and 1986 Tchaikovsky International Piano Competition Winner Barry Douglas.
Barry Douglas, Founder and Artistic Director of Camerata Ireland said;
“Following a successful tour in China last year we are delighted to be back, and it is particularly special for our Solo Flautist Eimear McGeown as this tour marks her Chinese debut. On behalf of everyone in Camerata Ireland I would like to take this opportunity to thank our global sponsor, Randox, without whom our international touring would not be possible. We are delighted to be able to work together across the world to showcase our musical and business talent to a global audience.”
The Camerata Ireland tour of China is as follows: Friday 9th December in The Shanghai Grand Theatre in Shanghai, in the Forbidden City Concert Hall in Bejing on the 10th and for the final installment of their China tour, Camerata Ireland will perform in the Wuhan Qintai Concert Hall in Wuhan.
For more information about the launch of our Chinese market growth initiative, please contact email@example.com
A number of business leaders and MLAs from Northern Ireland took time to meet with members of our Randox team based in China this week.
The group visited China in a bid to develop and nurture business relationships between the two countries, during a trip organised by the Northern Ireland Assembly Business Trust.
The Trust works to forge business relationships between local businesses and parliamentarians in Northern Ireland, offering a unique opportunity for each to better understand the industry in which they operate. The Trust organises educational visits, fellowships, seminars and trips for local businesses and MLAs to encourage participation on issues of mutual interest.
David Hu and Karen Li, members of Team Randox based in China, met with the group made up of MLAs Colin McGrath, Conor Murphy, Danny Kennedy, Clare Bailey, Kellie Armstrong, and Joanne Dobson, Stephen Kelly, Chief Executive of Manufacturing NI, Colin Neill, the head of Pubs of Ulster, and representatives from the Confucius Institute at Ulster University, an organisation which aims to develop academic, cultural, economic and social ties between Northern Ireland and China.
The group’s trip also involved a visit to the Shenyang Party Congress and Department for Commerce, and to the Irish Embassy in Beijing.
Susan Hammond, Randox China Sales Manager, commented;
“As a key market we have for the past 20 years exported to and worked across China, where Randox is a well-known and respected brand within the healthcare landscape. It is our dedication and hard work within this dynamic market, through both our HQ based team in Northern Ireland and our dedicated local team spread across China, that has enabled this. Our success so far drives us in our continued efforts in growth in this market, and our continued investment in introducing new and innovative products to the market.”
David Hu, Business Development Executive at Randox China, commented;
“It was a fantastic occasion meeting with the delegation from Northern Ireland. We work very closely with the team at Randox HQ in County Antrim, and so we relish the opportunity to engage and develop relationships with relevant representatives from Northern Ireland, whether in the political or business sphere. We’re delighted to be able to gain further insight into the relationships that exist between our two prosperous nations and look forward to nurturing these relationships in the future.”
For further information about our team in China, please contact our Randox PR Team.
T: 028 9445 1016